Progressive Care Statistics
Total Valuation
RXMD has a market cap or net worth of 13.49 million. The enterprise value is 6.47 million.
| Market Cap | 13.49M |
| Enterprise Value | 6.47M |
Important Dates
The last earnings date was Friday, November 15, 2024.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RXMD has 6.39 million shares outstanding. The number of shares has increased by 111.00% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 6.39M |
| Shares Change (YoY) | +111.00% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 21.35% |
| Owned by Institutions (%) | 3.86% |
| Float | 3.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.28 |
| PB Ratio | 0.78 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.49 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.41, with an EV/FCF ratio of 6.95.
| EV / Earnings | -0.33 |
| EV / Sales | 0.12 |
| EV / EBITDA | 2.41 |
| EV / EBIT | n/a |
| EV / FCF | 6.95 |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.01 |
| Quick Ratio | 1.77 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.57 |
| Debt / FCF | 1.63 |
| Interest Coverage | -0.30 |
Financial Efficiency
Return on equity (ROE) is -177.59% and return on invested capital (ROIC) is -2.18%.
| Return on Equity (ROE) | -177.59% |
| Return on Assets (ROA) | -1.36% |
| Return on Invested Capital (ROIC) | -2.18% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 383,804 |
| Profits Per Employee | -136,566 |
| Employee Count | 143 |
| Asset Turnover | 2.23 |
| Inventory Turnover | 18.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.75% in the last 52 weeks. The beta is -0.21, so RXMD's price volatility has been lower than the market average.
| Beta (5Y) | -0.21 |
| 52-Week Price Change | -47.75% |
| 50-Day Moving Average | 1.77 |
| 200-Day Moving Average | 2.21 |
| Relative Strength Index (RSI) | 56.69 |
| Average Volume (20 Days) | 998 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.34 |
Income Statement
In the last 12 months, RXMD had revenue of 54.88 million and -19.53 million in losses. Loss per share was -2.65.
| Revenue | 54.88M |
| Gross Profit | 17.16M |
| Operating Income | -534,000 |
| Pretax Income | -24.30M |
| Net Income | -19.53M |
| EBITDA | 2.46M |
| EBIT | -534,000 |
| Loss Per Share | -2.65 |
Balance Sheet
The company has 8.54 million in cash and 1.52 million in debt, giving a net cash position of 7.02 million or 1.10 per share.
| Cash & Cash Equivalents | 8.54M |
| Total Debt | 1.52M |
| Net Cash | 7.02M |
| Net Cash Per Share | 1.10 |
| Equity (Book Value) | 16.98M |
| Book Value Per Share | 2.72 |
| Working Capital | 10.75M |
Cash Flow
In the last 12 months, operating cash flow was 1.53 million and capital expenditures -601,000, giving a free cash flow of 931,000.
| Operating Cash Flow | 1.53M |
| Capital Expenditures | -601,000 |
| Free Cash Flow | 931,000 |
| FCF Per Share | 0.15 |
Margins
Gross margin is 31.26%, with operating and profit margins of -0.97% and -44.27%.
| Gross Margin | 31.26% |
| Operating Margin | -0.97% |
| Pretax Margin | -44.27% |
| Profit Margin | -44.27% |
| EBITDA Margin | 4.49% |
| EBIT Margin | -0.97% |
| FCF Margin | 1.70% |
Dividends & Yields
RXMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -111.00% |
| Shareholder Yield | -111.00% |
| Earnings Yield | -125.70% |
| FCF Yield | 6.90% |
Stock Splits
The last stock split was on December 30, 2022. It was a reverse split with a ratio of 0.005.
| Last Split Date | Dec 30, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.005 |
Scores
RXMD has an Altman Z-Score of 1.23. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.23 |
| Piotroski F-Score | n/a |